• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清γ-谷氨酰转移酶/谷丙转氨酶比值可预测乙肝相关肝癌的血管侵犯。

Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC.

作者信息

Zhao Zhifeng, Zhu Yiming, Ni Xiaochun, Lin Jiayun, Li Hongjie, Zheng Lei, Zhang Chihao, Qi Xiaoliang, Huo Haizhong, Lou Xiaolou, Fan Qiang, Bao Yongyang, Luo Meng

机构信息

Department of General Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhizaoju Road, Huangpu District, Shanghai, People's Republic of China.

Department of Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhizaoju Road, Huangpu District, Shanghai, People's Republic of China.

出版信息

Cancer Cell Int. 2021 Sep 28;21(1):517. doi: 10.1186/s12935-021-02214-1.

DOI:10.1186/s12935-021-02214-1
PMID:34583704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8479900/
Abstract

BACKGROUND

The gamma-glutamyl transferase (GGT) to alanine aminotransferase (ALT) ratio has been reported as an effective predictor of the severity of hepatitis and HCC. The purpose of this study was to determine the role of the GGT/ALT ratio in the prediction of vascular invasion and survival outcomes in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

METHODS

The risk factors for vascular invasion were determined by univariate/multivariate logistic analysis. The cut-off value of GGT/ALT in predicting vascular invasion was calculated using the receiver operating characteristic (ROC) curve. The prognostic value of GGT/ALT was examined by Cox analysis and Kaplan-Meier curves. Sensitivity analysis, such as subgroup analysis and propensity score matching (PSM), was performed to reduce potential confounding bias.

RESULTS

A high GGT/ALT ratio was identified as an independent risk factor for vascular invasion (P = 0.03). The correlation analysis suggested that higher GGT/ALT was associated with more severe tumour burdens, including vascular invasion (P < 0.001), tumour volume > 5 cm (P < 0.001), poor pathological differentiation (P = 0.042), more severe BCLC (P < 0.001) and ALBI grade (P = 0.007). In the survival analysis, a high GGT/ALT ratio was associated with poor overall survival (OS) (HR: 1.38; 95% CI 1.03, 1.87; P < 0.0001) and disease-free survival (DFS) (HR: 1.32; 95% CI 1.03, 1.87; P < 0.0001). In the subgroup analysis, similar results were consistently observed across most subgroups. In PSM analysis, GGT/ALT remained independently associated with vascular invasion (OR, 186; 95% CI 1.23, 3.33).

CONCLUSION

The GGT/ALT ratio was a potential effective factor in the prediction of vascular invasion and prognosis in patients with HBV-related HCC.

摘要

背景

γ-谷氨酰转移酶(GGT)与丙氨酸氨基转移酶(ALT)的比值已被报道为肝炎和肝癌严重程度的有效预测指标。本研究的目的是确定GGT/ALT比值在预测乙型肝炎病毒(HBV)相关肝细胞癌(HCC)患者血管侵犯和生存结局中的作用。

方法

通过单因素/多因素逻辑分析确定血管侵犯的危险因素。使用受试者工作特征(ROC)曲线计算GGT/ALT预测血管侵犯的临界值。通过Cox分析和Kaplan-Meier曲线检验GGT/ALT的预后价值。进行敏感性分析,如亚组分析和倾向评分匹配(PSM),以减少潜在的混杂偏倚。

结果

高GGT/ALT比值被确定为血管侵犯的独立危险因素(P = 0.03)。相关性分析表明,较高的GGT/ALT与更严重的肿瘤负荷相关,包括血管侵犯(P < 0.001)、肿瘤体积>5 cm(P < 0.001)、病理分化差(P = 0.042)、更严重的BCLC(P < 0.001)和ALBI分级(P = 0.007)。在生存分析中,高GGT/ALT比值与总生存期(OS)差(HR:1.38;95%CI 1.03,1.87;P < 0.0001)和无病生存期(DFS)差(HR:1.32;95%CI 1.03,1.87;P < 0.0001)相关。在亚组分析中,大多数亚组均一致观察到类似结果。在PSM分析中,GGT/ALT仍与血管侵犯独立相关(OR,1.86;95%CI 1.23,3.33)。

结论

GGT/ALT比值是预测HBV相关HCC患者血管侵犯和预后的潜在有效因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/3481a79fdb56/12935_2021_2214_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/af9f6d03ac54/12935_2021_2214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/3cb05c0c3872/12935_2021_2214_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/235f13ec415f/12935_2021_2214_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/34ea2009b19d/12935_2021_2214_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/89ca6158edc3/12935_2021_2214_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/17de1e3b6583/12935_2021_2214_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/3481a79fdb56/12935_2021_2214_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/af9f6d03ac54/12935_2021_2214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/3cb05c0c3872/12935_2021_2214_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/235f13ec415f/12935_2021_2214_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/34ea2009b19d/12935_2021_2214_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/89ca6158edc3/12935_2021_2214_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/17de1e3b6583/12935_2021_2214_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1559/8479900/3481a79fdb56/12935_2021_2214_Fig7_HTML.jpg

相似文献

1
Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC.血清γ-谷氨酰转移酶/谷丙转氨酶比值可预测乙肝相关肝癌的血管侵犯。
Cancer Cell Int. 2021 Sep 28;21(1):517. doi: 10.1186/s12935-021-02214-1.
2
Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.术前血清γ-谷氨酰转移酶与丙氨酸氨基转移酶比值是Child-Pugh A级肝细胞癌术后便捷的预后标志物。
J Gastroenterol. 2009;44(6):635-42. doi: 10.1007/s00535-009-0050-x. Epub 2009 Apr 22.
3
A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.一种新的血浆生物标志物可增强肝细胞癌患者术后急性肾损伤的临床预测。
Clin Chim Acta. 2017 Dec;475:128-136. doi: 10.1016/j.cca.2017.10.008. Epub 2017 Oct 12.
4
LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.LDH 和 GGT/ALT 比值可作为肝癌肝移植术后患者的新型预后生物标志物。
Comput Math Methods Med. 2021 Nov 20;2021:9809990. doi: 10.1155/2021/9809990. eCollection 2021.
5
Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy.肝切除术后米兰标准内肝细胞癌中炎症和营养生物标志物联合检测的预后价值
Front Oncol. 2022 Sep 5;12:947302. doi: 10.3389/fonc.2022.947302. eCollection 2022.
6
A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.一种基于联合全身和肝脏炎症标志物的新型预后评分模型在乙型肝炎病毒相关性肝细胞癌患者预后中的应用。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2246-2255. doi: 10.1080/21691401.2019.1573174.
7
Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.血清丙氨酸氨基转移酶/天冬氨酸氨基转移酶(ALT/AST)比值和γ-谷氨酰转移酶(GGT)在食管鳞癌患者中的预后价值。
BMC Cancer. 2017 Aug 14;17(1):544. doi: 10.1186/s12885-017-3523-y.
8
Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.术前血清γ-谷氨酰转肽酶升高预示肝移植后肝细胞癌预后不良。
Sci Rep. 2016 Jul 6;6:28835. doi: 10.1038/srep28835.
9
Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection.术前联合白蛋白-胆红素(ALBI)和血清γ-谷氨酰转肽酶(GGT)可预测肝细胞癌患者肝切除术后的预后。
J Cancer. 2019 Aug 27;10(20):4836-4845. doi: 10.7150/jca.33877. eCollection 2019.
10
Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.γ-谷氨酰转肽酶与淋巴细胞比值对伴微血管侵犯的肝细胞癌患者的预测价值。
BMC Cancer. 2020 Feb 18;20(1):132. doi: 10.1186/s12885-020-6628-7.

引用本文的文献

1
Clinical significance of immune cell and biomarker changes in liver cancer.肝癌中免疫细胞和生物标志物变化的临床意义
World J Gastrointest Surg. 2025 Jun 27;17(6):104923. doi: 10.4240/wjgs.v17.i6.104923.
2
Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter.基于血小板计数与脾脏直径比值的肝细胞癌患者生存分析
Front Pharmacol. 2025 Jan 6;15:1449603. doi: 10.3389/fphar.2024.1449603. eCollection 2024.
3
The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma.

本文引用的文献

1
Raman-Enhanced Spectroscopy (RESpect) Probe for Childhood Non-Hodgkin Lymphoma.用于儿童非霍奇金淋巴瘤的拉曼增强光谱(RESpect)探头。
SciMed J. 2020 Mar;2(1):1-7. doi: 10.28991/scimedj-2020-0201-1.
2
The vascular landscape of human cancer.人类癌症的血管格局。
J Clin Invest. 2021 Jan 19;131(2). doi: 10.1172/JCI136655.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
血清长链非编码RNA PTTG3P与信使核糖核酸PTTG1的联合检测可作为肝细胞癌的诊断和预后标志物。
Mol Med Rep. 2025 Feb;31(2). doi: 10.3892/mmr.2024.13409. Epub 2024 Dec 5.
4
Toxicological Evaluation of Kaempferol and Linearolactone as Treatments for Amoebic Liver Abscess Development in .槲皮素和开环异落叶松脂醇内酯治疗肝阿米巴脓肿发展的毒理学评价
Int J Mol Sci. 2024 Oct 2;25(19):10633. doi: 10.3390/ijms251910633.
5
Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model.TACE联合消融治疗的低白蛋白-胆红素分级患者肝细胞癌的复发:随机森林Cox预测模型
J Hepatocell Carcinoma. 2024 Jul 8;11:1375-1388. doi: 10.2147/JHC.S465962. eCollection 2024.
6
A New Assessment of Two Transferase-Based Liver Enzymes in Low- and High-Fibrosis Patients Chronically Infected with Hepatitis B Virus: A Meta-Analysis and Pilot Study.对慢性乙型肝炎病毒感染的低纤维化和高纤维化患者两种基于转移酶的肝酶的新评估:一项荟萃分析和初步研究
J Clin Med. 2024 Jul 3;13(13):3903. doi: 10.3390/jcm13133903.
7
Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments.将炎症标志物和临床指标纳入原发性局部区域治疗后单发性小肝细胞癌复发的预测模型
J Hepatocell Carcinoma. 2024 Jun 13;11:1113-1125. doi: 10.2147/JHC.S465069. eCollection 2024.
8
The transcription factor TBP promotes hepatocellular carcinoma progression by activating AKT3.转录因子TBP通过激活AKT3促进肝细胞癌进展。
Am J Cancer Res. 2023 Nov 15;13(11):5656-5666. eCollection 2023.
9
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.治疗前γ-谷氨酰转移酶可预测核苷(酸)类似物治疗慢性乙型肝炎患者的死亡率。
Kaohsiung J Med Sci. 2024 Feb;40(2):188-197. doi: 10.1002/kjm2.12771. Epub 2023 Oct 27.
10
A new model based on gamma-glutamyl transpeptidase to lymphocyte ratio and systemic immune-inflammation index can effectively predict the recurrence of hepatocellular carcinoma after liver transplantation.一种基于γ-谷氨酰转肽酶与淋巴细胞比值及全身免疫炎症指数的新模型能够有效预测肝移植术后肝细胞癌的复发。
Front Oncol. 2023 Apr 20;13:1178123. doi: 10.3389/fonc.2023.1178123. eCollection 2023.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Rule of changes in serum GGT levels and GGT/ALT and AST/ALT ratios in primary hepatic carcinoma patients with different AFP levels.血清 GGT 水平及 GGT/ALT 和 AST/ALT 比值变化规律在不同 AFP 水平原发性肝癌患者中的变化。
Cancer Biomark. 2018;21(4):743-746. doi: 10.3233/CBM-170088.
5
Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.乙型肝炎病毒感染和活跃复制促进肝细胞癌中血管侵犯的形成。
BMC Cancer. 2017 May 2;17(1):304. doi: 10.1186/s12885-017-3293-6.
6
Recurrent Hepatocellular Carcinoma After Liver Transplantation: Analysis of Risk Factors.肝移植术后复发性肝细胞癌:危险因素分析
Transplant Proc. 2016 Nov;48(9):2990-2993. doi: 10.1016/j.transproceed.2016.09.020.
7
Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.碱性磷酸酶、γ-谷氨酰转肽酶和乳酸脱氢酶对肝癌患者行肝切除术后的预后价值。
Int J Surg. 2016 Dec;36(Pt A):143-151. doi: 10.1016/j.ijsu.2016.10.033. Epub 2016 Oct 25.
8
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.
9
Increased serum gamma-glutamyltransferase levels are associated with ventricular instability in type 2 diabetes.血清γ-谷氨酰转移酶水平升高与2型糖尿病患者的心室不稳定有关。
Endocrine. 2016 Apr;52(1):63-72. doi: 10.1007/s12020-015-0760-1. Epub 2015 Oct 3.
10
Alanine aminotransferase and gamma-glutamyl transferase have different dose-response relationships with risk of mortality by age.丙氨酸氨基转移酶和γ-谷氨酰转移酶与年龄相关的死亡率的剂量反应关系不同。
Liver Int. 2016 Jan;36(1):126-35. doi: 10.1111/liv.12879. Epub 2015 Jun 26.